These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 28918087)

  • 1. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
    Dakay K; Chang AD; Hemendinger M; Cutting S; McTaggart RA; Jayaraman MV; Chu A; Panda N; Song C; Merkler A; Gialdini G; Kummer B; Lerario MP; Kamel H; Elkind MSV; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):192-197. PubMed ID: 28918087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.
    Yaghi S; Liberman AL; Henninger N; Grory BM; Nouh A; Scher E; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Fakhri H; Espaillat KB; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Trivedi T; Ishida K; Frontera J; Lord A; Furie K; Keyrouz S; de Havenon A; Mistry E; Leon Guerrero CR; Khan M
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104888. PubMed ID: 32414583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Left Atrial Enlargement on the Relationship between Atrial Fibrillation and Stroke.
    Broughton ST; O'Neal WT; Salahuddin T; Soliman EZ
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1396-402. PubMed ID: 27012217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK; Lee MJ; Kim JH; Lee JS; Park RW; Kim GM; Chung CS; Lee KH; Kim JS; Lee SY; Bang OY
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1383-1390. PubMed ID: 28412319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.
    Yaghi S; Moon YP; Mora-McLaughlin C; Willey JZ; Cheung K; Di Tullio MR; Homma S; Kamel H; Sacco RL; Elkind MS
    Stroke; 2015 Jun; 46(6):1488-93. PubMed ID: 25908460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Ischemic Stroke in High Risk Atrial Fibrillation Patients during Periods of Warfarin Discontinuation for Surgical Procedures.
    Qureshi AI; Jahangir N; Malik AA; Afzal MR; Orfi F; Suri MF
    Cerebrovasc Dis; 2016; 42(5-6):346-351. PubMed ID: 27322535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.